NASDAQ:ILMN
Illumina Stock News
$114.46
-0.550 (-0.478%)
At Close: May 16, 2024
Here's Why You Shouldn't Buy the Dip With Illumina Stock
08:10am, Friday, 14'th Apr 2023
Illumina hasn't been a great investment over the last five years. Its troubles with the Grail acquisition are only part of the story.
Is There Any Hope for Illumina Stock?
09:37am, Saturday, 08'th Apr 2023
Illumina's latest earnings report was a bit of a let down. It will also probably be forced to divest a company it recently acquired.
Carl Ican Issues Another Letter to Illumina Shareholders
05:55pm, Wednesday, 05'th Apr 2023
Investor Contacts:
Carl Icahn says Illumina's appeal of FTC order to divest Grail is ‘an almost impossible battle'
04:33pm, Wednesday, 05'th Apr 2023
Carl Icahn shares common ground with the FTC, which argued that Illumina's acquisition of cancer test developer Grail would stifle competition and innovation.
Illumina's (ILMN) NovaSeq X Exceeds 200 Order Milestone
12:56pm, Wednesday, 05'th Apr 2023
Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument.
Carl Icahn Writes Another Letter to Illumina Shareholders
05:52pm, Tuesday, 04'th Apr 2023
Sunny Isles Beach, Florida, April 3, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial).
FTC orders Illumina to divest cancer detection test maker Grail to protect competition; Illumina to appeal
01:55pm, Monday, 03'rd Apr 2023
The Federal Trade Commission (FTC) has issued an Opinion and Order requiring DNA sequencing provider, Illumina Inc (NASDAQ:ILMN), to divest Gral Inc, which makes a multi-cancer early detection (MCE
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
01:25pm, Monday, 03'rd Apr 2023
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell on the news.
Illumina: ‘Ichan doesn't fully understand growth projections of this company,' analyst says
11:49am, Monday, 03'rd Apr 2023
RBC Capital Markets Equity Research Analyst Conor McNamara joins Yahoo Finance Live to discuss the proxy battle between Illumina and activist investor Carl Ichan, risks of closing the GRAIL acquisitio
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
11:11am, Monday, 03'rd Apr 2023
The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal.
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
10:44am, Monday, 03'rd Apr 2023
The agency said the combination would hurt competition for cancer-detection tests while raising prices.
Carl Icahn blasts Illumina for nearly doubling CEO's pay despite steep drop in market value
12:17pm, Friday, 31'st Mar 2023
Activist investor Carl Icahn ramped up his proxy fight against Illumina with a blistering statement.
7 Stocks Gearing Up for a Major Breakout
12:17pm, Friday, 31'st Mar 2023
The entire stock market is gearing up for a major breakout as investors are becoming convinced that the banking sector has stabilized and that the Federal Reserve is, at the very least, almost done hi
Illumina (ILMN) to Enable Tertiary Analysis With New Launch
01:46pm, Wednesday, 29'th Mar 2023
Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.
Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifies
10:24am, Wednesday, 29'th Mar 2023
Icahn said Illumina should bring back former CEO Jay Flatley, saying current management is making the mistake of holding onto the $7.1 billion Grail deal.
